In this interview with Andrew Kleuss on Investors Hub, Vitaliy makes the case that concerns over Amazon’s entry into the pharmaceuticals business are probably overblown. To parse this problem, Vitaliy differentiates between pharmacies and drug distributors, and analyzes the extent to which Amazon can compete with both. While Amazon might place some pressure on pharmacies over time, he explains how drug distributors’ unique supply chains should remain robust against a competitive threat from Amazon.
Related Articles
Lessons for My Kids – Conversations with Vitaliy – Ep 16
What lessons do you want to leave behind for your kids? 📩 Sign up for my free weekly email newsletter 🎙 Check out my weekly podcast, The Intellectual Investor. 📚 GET MY BOOKS Soul in the Game - The Little Book of Sideways...
Don’t Let History Repeat Itself – Ep 208
I know young adults who have gone to Israel to fight to protect it from evil. I have friends who have put their lives on hold and gone to Israel to volunteer to help that country in any way they can. My pen is my gift. This is how I can make a...
Israel is Not Hamas’ Final Solution – Ep 207
I usually look forward to waking up every morning. My family is still asleep. I make a cup of coffee, put on my headphones, and write. But I wasn't looking forward to mornings over the last week while I was working on this and tomorrow’s essays. It...
How To Teach Your Kids To Read – Conversations with Vitaliy – Ep 15
Without a doubt, this is one of the most difficult things to do in a world dominated by technology. I hope my advice helps in some way. 📩 Sign up for my free weekly email newsletter 🎙 Check out my weekly podcast, The Intellectual...
